A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 t (Q47201041)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2017

Language	Label	Description	Also known as
English	A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 t	scientific article published in December 2017

Statements

scholarly article

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial (English)

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Michel Noutsias

22

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Krzysztof Milewski

object named as

Krzysztof P Milewski

4

0 references

object named as

William Wijns

25

0 references

Patrick W Serruys

26

object named as

Patrick W Serruys

1 reference

Europe PubMed Central

11 January 2018

5

object named as

Philipp Lurz

1 reference

Europe PubMed Central

11 January 2018

6

object named as

Pawel Buszman

1 reference

Europe PubMed Central

11 January 2018

Guillaume Cayla

14

object named as

Guillaume Cayla

1 reference

Europe PubMed Central

11 January 2018

Yoshinobu Onuma

24

object named as

Yoshinobu Onuma

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Aleksander Żurakowski

17

object named as

Aleksander Żurakowski

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Gillian A J Jessurun

7

object named as

Gillian A J Jessurun

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

15

object named as

Sjoerd H Hofma

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

2

object named as

Yuki Katagiri

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Robbert J de Winter

1

object named as

Robbert J de Winter

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

3

object named as

Taku Asano

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

E Karin Arkenbout

21

object named as

E Karin Arkenbout

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Roland P T Troquay

9

object named as

Roland P T Troquay

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Ton Oude Ophuis

11

object named as

Ton Oude Ophuis

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

12

object named as

Jochen Wöhrle

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Maciej Kośmider

19

object named as

Maciej Kośmider

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

13

object named as

Rafał Wyderka

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

author name string

Karel T Koch

8

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Bas J B Hamer

10

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Sébastien Levesque

16

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Dieter Fischer

18

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Pascal Goube

20

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Markus W Ferrari

23

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

language of work or name

0 references

publication date

1 December 2017

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In-stent neoatherosclerosis: a final common pathway of late stent failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

First-in-Human Evaluation of a Bioabsorbable Polymer–Coated Sirolimus-Eluting Stent

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thin fluoropolymer films and nanoparticle coatings from the rapid expansion of supercritical carbon dioxide solutions with electrostatic collection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drug

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatmen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronar

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cyclin-dependent kinase inhibitors in vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2817%2933103-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(17)33103-3

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

1 reference

Europe PubMed Central

11 January 2018

http://europepmc.org/abstract/MED/29203070

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47201041&oldid=2116831836"